19 states have seen increasing cases of coronovirus and Arizona is asking its hospitals to activate emergency plans

19 states have seen increasing cases of coronovirus and Arizona is asking its hospitals to activate emergency plans
Health experts have long warned of a second spike in the Covid-19, and now an increase in cases has prompted Arizona to speed up emergency plans to its hospitals.

Arizona is one of 19 states in which the trend of new coronovirus cases is still increasing. While 24 are trending downward, the trend is stable in seven states. Nationwide, more than 1.9 million people have been infected with the virus and more than 112,000 have died, according to Johns Hopkins University data.

At its peak, Arizona intensive care unit beds were 78% used. As of Monday, 76% were busy. Arizona's Director of Health Services Drs. Kara Christ called for being "prudent" in elective surgery to ensure bed capacity in hospitals.

We know that Covid-19 is still in our community, and we expect to see an increase in cases, ”the Arizona Department of Health Services tweeted Tuesday night.

Bed capacity and medical resources were among the top concerns in treating the coronovirus epidemic when the nation was at its peak. Health experts say that it is, if not, that the country makes another increase in cases that may once again affect health systems.

Several states have relaxed restrictions imposed since March to prevent the spread of the virus. But without the vaccine and more people flocking to public spaces and national protests, health experts have warned that the high case rates seen in the spring may return.

Concerns around the country.

In cases the fear of another spike spreads across the United States.

According to the North Carolina Health Association, North Carolina recently broke the record for the number of people hospitalized with coronavirus. The reported hospitals are 774.

While there is a lot of capacity left in hospitals, states are worried about the trends in hospitals when the restrictions were first increased after rest and then Memorial Day weekend, the agency said.

And said that people in the grip of the epidemic are already alert.

On Tuesday, 375 new positive cases and 91 coronovirus-related deaths, the New Jersey number was improving. But states do not yet believe that it is out of danger. Gov. Phil Murphy said at a press conference.

And Los Angeles is encouraging those who have participated in protests in George Floyd's death to monitor symptoms, fearing large gatherings may offer the possibility of spreading the virus.

Los Angeles County Director of Public Health Barbara Ferrer said during a conference call, "It may be an exposure and it will not be obtained through a contact location system. Nobody knows it has no name." Press on Monday.

Barriers to treatment and vaccines.

As states have implemented measures to manage the epidemic, the director of the National Institute of Allergy and Infectious Diseases, Drs. Anthony Fauci said, the path to medical intervention is a long one.

Researchers around the world will need the work to provide billions of potential vaccine supplements to all researchers around the world, he said in a taped interview with the president and CEO of the organization for biotechnology innovation, Michelle McMary-Heath.

And while FDA pathologists hope to have many coronovirus vaccines in the future, the number of people who won't take advantage of it puts their collective immunity at risk, Drs. Peter Marks, director of the Centers for Food Administration and American Medicines for American Biological Assessment and Research, he said.

"Remember that it is 30% or 40% of the population that will not take this vaccine, even if the effectiveness of the vaccine is 70 or 80%. We will not be in a state of collective immunity," he said.

And as research progresses toward a vaccine, clinical trials of treatment are also underway, according to the National Institutes of Health: 201 were underway in March.

But researchers at the Johns Hopkins Bloomberg School of Public Health said most of them lacked significant scientific components. There was no control group, no treatment to be compared with which to compare outcomes, very few participants enrolled, and volunteers and physicians unaware of who received treatment or not, which has been shown to be prejudicial result.

"Given the readiness to identify definitive evidence on possible Kovid-19 treatments, this is a case where we wish we 'did not need more research' because of the basic shortcomings of trial design and small trials." Lead author Hemalkumar Mehta, an assistant professor at Bloomberg School of Public Health, said in a press release.

The readiness for treatment is as sharp as the current supply of Remedisvir from the US government. A US, Department of Health and Human Services official told CNN that the only drug known to work, comes out later this month. USA, Dr. Robert Kadlec. And while the company that produces it will produce more, it is unclear how much will be available during the summer.

Post a Comment